Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/10/037416
CTRI/2021/10/037416
Not yet recruiting
Phase 2

Subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after Penetrating Keratoplasty, A Prospective,Open Label,Non Comparative study

SNMedical College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: - Health Condition 2: H598- Other intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: H598- Other intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified
Sponsor
SNMedical College
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
SNMedical College

Eligibility Criteria

Inclusion Criteria

  • •1\)patients having 2 or more than 2 quadrant corneal neovascularisation
  • •2\)patients who developed corneal neovascularisation during F/U ,not responding to conventional medical treatment .
  • •3\)patients who gave consent to be in follow up.

Exclusion Criteria

  • •1\)patients having persistent epithelial defect
  • •2\)patients who were systemically not fit for subconj Bevacizumab injection;pts with H/O recent attack of M.I.,stroke and uncontrolled Hypertension.
  • •3\)pregnant female

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurity
JPRN-UMIN000014316Kansai Medical University15
Completed
Not Applicable
The intravitreal injection of Bevacizumab for retinopathy of prematurityretinopathy of prematurity
JPRN-UMIN000028770Department of Ophthalmology, Shiga University of Medical Science24
Not yet recruiting
Not Applicable
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurity
JPRN-UMIN000007465Tokushima university hospital10
Not yet recruiting
Not Applicable
Subtenon injection of bevacizumab for retinal vein occulusioretinal vein occulusion
JPRN-UMIN000005254Department of Ophthalmology, Keio University School of Medicine40
Recruiting
Not Applicable
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesions
JPRN-UMIN000020916Keio University, School of Medicine1,000